Thanks Michael. As we discussed on our fourth quarter earnings call, our view at the time was that increases in M&A activity this year would take longer to materialize due to geopolitical uncertainty. That view still holds true even more so now. As expected, the more liquid markets are bearing the brunt of the current volatility with wider credit spreads and uneven trading. Over the last month, spreads have also begun to widen on certain private direct lending deals due to the market volatility. As Michael noted earlier, we have been in close contact with sponsors and management teams and have run extensive analysis in an effort to stay up-to-date with the latest tariff policies and impacted countries. Additionally, as we originate new investments, we are evaluating each deal for potential risks related to tariffs or DOGE. As a result, we believe we have a good understanding of the first order potential tariff impacts on the portfolio. However, we remain cautious as second or third order impacts are still unknown. And depending on the ultimate tariff resolution may take real time to play out. Based on our current portfolio analysis, we believe approximately 8% of our portfolio could have direct exposure to tariff policies, should they become permanent. And while DOGE exposure is more difficult to quantify, we currently estimate low to mid-single-digit DOGE exposure. The industry is most impacted by potential tariff policies; our consumer durables, consumer discretionary, consumer staples, and industrials, which falls within our capital goods classification. The industry is most impacted by those are software and services, health care equipment and services and aerospace and defense, which falls within our capital goods classification. I would clarify that this information is top down in nature, and therefore, it remains too early to attempt to specifically quantify what impacts these items could have on individual portfolio companies from an EBITDA and free cash flow perspective. The good news is our typical portfolio company tends to be large and a market share leader and therefore, maintain highly diversified customer and supplier relationships. As a result, these companies typically enjoy more pricing power, which allows them to pass through price increases compared to smaller companies. Since identifying potential tariff-related headwinds in November, we have taken a proactive approach to managing exposure across the portfolio. Notably, during the quarter, we achieved a full exit on 2 portfolio companies that we believe exhibited more risk from a tariff and cycle standpoint. The first example, 360 Group is a company whose products are primarily sourced from China. The second example Lakeview Farms, Lakeview Farms is a food products business, subject to consumer purchasing behavior. We are pleased with both outcomes as the investments were repaid at par. Another bright spot is our asset-based finance portfolio, which we view as particularly compelling during periods like this. Traditional secured and unsecured corporate credit investing hinges largely on future earnings forecast and cash flow assumptions, which are obviously vulnerable to macro shifts. ABS investments by contrast, are anchored and contractual structures tied directly to tangible collateral. We would note, however, that we are mindful about our consumer-related exposure in our ABS portfolio, though we are focused almost entirely on secured risk or high FICO score prime borrowers. Overall, we continue to be bullish on ABS positive impact to our portfolio and the diversification benefits it provides. Turning to FSK's investment activity. During the first quarter, we originated approximately $2 billion of new investments. Approximately 45% of our new investments were focused on add-on financings to existing portfolio companies and long-term KKR relationships. Our new investments combined with $1.1 billion of net sales and repayments, when factoring in sales to our joint venture equated to a net portfolio increase of $881 million. New originations consisted of approximately 63% in first lien loans, 1% in other senior secured debt, 19% in asset-based finance, 15% in capital costs to the joint venture and 2% in equity and other investments. Our new direct lending investment commitments added a weighted average EBITDA of approximately $257 million, 5.5 times leverage through our security and a weighted average coupon of approximately SOFR plus 505 basis points. Though the first quarter of the year has traditionally resulted in seasonally slower new originations, this has been our strongest origination quarter from both a total and net deployment perspective since 2022. Despite the sluggishness of the US M&A market, during the first quarter, we experienced strong origination activity driven by our expansive deal funnel, which continues to generate robust diversified deal flow. Our private credit team maintained strong sponsor relationships on a global basis, and our large base of incumbent borrowers remains a consistent and valuable source of repeat opportunities. We remain focused on the upper middle market or companies with $50 million to $150 million of EBITDA, which tend to have more levers they can pull during challenging periods. In an environment like this, we're acutely focused on investing in high-quality companies with strong defensive positions. The weighted average EBITDA of our portfolio companies was $255 million, and the median EBITDA was $120 million as of March 31, 2025. Our portfolio companies reported a weighted average year-over-year EBITDA growth rate of approximately 10% across companies in which we have invested since April of 2018. Interest coverage levels remained steady with the median first quarter coverage at 1.7 times, unchanged quarter-over-quarter. At the end of first quarter, non-accruals represented 3.5% of our portfolio on a cost basis and 2.1% of our portfolio on a fair value basis. This compares to 3.7% of our portfolio on a cost basis and 2.2% of our portfolio on a fair value basis as of December 31, 2024. We also believe it is helpful to provide the market with information based on FSK assets originated by KKR credit. Non-accruals relating to the 90% of our total portfolio, which has been originated by KKR Credit and the FS KKR Adviser were 2% on a cost basis and 1% on a fair value basis as of the end of the first quarter. This compares to 2% on a cost basis and 0.8% on a fair value basis as of the end of the fourth quarter. During the first quarter, two investments were added to non-accrual status and three investments were removed. Our first lien senior secured position in new era was added to non-accrual, contributing $29 million of cost and $23 million of fair value. Additionally, our second lien investment in Cubic Corp. was added to non-accrual, contributing $43 million of cost and $34 million of fair value. Our position in Alacrity solutions was restructured during the quarter, which resulted in a $22 million of cost and $16 million of fair value being removed from non-accrual. Our position in Accuride was also restructured during the quarter, which resulted in $8 million of cost and $2 million of fair value being removed from non-accrual. Our remaining subordinated debt position in Miami Beach Medical was converted to equity in conjunction with the company's wind down, removing $18 million of cost and $12 million of fair value from non-accrual. Also during the quarter, JW Aluminum refinanced the $300 million high-yield bond with a new $350 million offering. This resulted in a $77 million par paydown on our senior secured bond and a $21 million paydown on our preferred equity position. Given this investment has been on non-accrual since Q4 2023, we are pleased with this outcome. Performance at JWA has been strong, and the company is a beneficiary of the recent tariff news. In terms of other portfolio updates, Production Resource Group and 4840 were our two largest markdowns during the first quarter. PRG continues to be impacted by certain tour cancellations and margin pressure and 4840 has been impacted by labor cost and excess inventory. Separately, we're pleased to note that the sale of Maverick Natural Resources, a legacy position, which has been in the portfolio since 2014, has closed. As a result, FSK received $18 million in cash and $25 million of diversified energy company common stock. With that, I'll turn the call over to Steve.